ArticleExperimental and therapeutic medicine2022

Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report.

Carmen Bobeica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.